Leading Pharmaceutical Biotech surged nearly 240% during the session and announced plans to acquire all shares of Conflux

2025/07/02 10:46

PANews reported on July 2 that the Hong Kong-listed company Leading Pharmaceutical Biotech (00399) surged in early trading today, soaring by nearly 240% at the beginning of the session. The increase then narrowed. The price once rose to HK$0.7 and has now retreated to around HK$0.34.

According to previous news, Leading Pharmaceutical Biotechnology plans to acquire all the shares of Conflux to expand into the blockchain field. The two founding members of Conflux will serve as its executive directors .

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.